The results of the study showed that Piperine was able to inhibit the volume and weight of tumors in vivo in CRC model mice, increased the levels of LC3, LC3-II, ROS, and Beclin1, and decreased the levels of p-AKT and mTOR. This evidence concerns the gene AKT1 and colorectal carcinoma.